• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, January 21, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Optometry Australia says work remains despite Medicare funding changes

by Staff Writer
February 14, 2025
in Associations, Business, Federal Government, Local, Medicare, News, Ophthalmic insights, Ophthalmic organisations, Optometry networks, Policy & regulation
Reading Time: 3 mins read
A A
eye injection incentive

According to Medicare data for 2023, 67% of people having eye injections were not bulk billed. Image: Robyn Mackenzie/Shutterstock.com.

Share on FacebookShare on Twitter

Optometry Australia (OA) says there is still work to be done despite the Federal Government implementing a number of recommendations by the MBS Review Taskforce relating to optometry Medicare items.

These changes, as part of the Federal Budget 2024-25, have been confirmed and come into effect from 1 March 2025.

“Many of these changes pleasingly align with those we actively advocated for, though not all the changes we sought have been implemented,” OA said in a statement to members.

“Whilst there has been an increase to the domiciliary item fee, this increase is insufficient and we will continue to advocate for a fee that better reflects the true cost of travelling and providing care outside of practice.”

OA said it would continue to keep members informed about Medicare changes and advocate for improvements that better support optometrists and their patients.

From 1 March 2025, the following changes will take effect:

  • Comprehensive consultations: Items 10912 and 10913 will combine into one item number, 10913, and the previous ‘same practice’ restrictions will be removed.
  • Visual fields: A third computerised perimetry test in a 12-month period where indicated by the presence of glaucoma with a high risk of clinically significant progression will be introduced. Explanatory notes will be reworded to emphasise the need for providers to clearly document the rationale underlying the need for the practitioner to perform a computerised perimetry test. The two new items that will be introduced are:
    • 10938 (bilateral) – $72.55 scheduled fee.
    • 10939 (monocular) – $43.80 scheduled fee.
  • Domiciliary visits: Items 10931 to 10933 will be replaced with a single item number, 10931, which covers all domiciliary visits. The scheduled fee is $43.75. The co-claiming restrictions on domiciliary visits will be removed, enabling the billing of a short consultation (10916 or 10918) and computerised perimetry (10940 or 10941) at domiciliary visits.
  • Contact lenses: Items 10921, 10922, 10923 and 10925 will combine into one item number, 10921, and the explanatory notes reworded to remove the requirement to deliver the lens.
  • Foreign body removal: Item 10944 will be amended to clarify the requirement for complete removal of the rust ring with a ferrous embedded foreign body, and to provide more clarity around when this item can be claimed.
  • Residual vision: Item 10942 will be amended to reflect current best practice for testing of residual vision.

More reading

Optometry Australia set to launch its Advanced Practice Recognition program

Changes at the top in Optometry Australia national board shuffle

Optometry Australia says Gov must reinstate two-yearly Medicare-subsidised eye exams

Related Posts

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

There are plenty of pathways to help optometrists and dispensers into practice ownership. Image: Fxquadro/stock.adobe.com.

Webinar to help dispensers, optometrists into ownership

by Staff Writer
January 21, 2026

Optical Dispensers Australia (ODA), Eyecare Plus, ProVision, Vision Connection and Eyebenefit are working together to guide entrepreneurs and open the...

The glasses have a number of microphones built into the frames. Image: Nuance Audio.

Research evaluates Nuance Audio glasses in lab, real world

by Staff Writer
January 20, 2026

EssilorLuxottica has announced new clinical findings from two studies, including one in Australia, evaluating the performance of Nuance Audio glasses,...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited